AAAAAA
Results: 1-25/44
Authors:
DALIANI D
ULMER RA
JACKOW C
PUGH W
GANSBACHER B
CABANILLAS F
DUVIC M
SARRIS AH
Citation: D. Daliani et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA, BUT NOT HTLV-I TAX,ARE LIKELY FACTORS IN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA VIA INDUCTION OF INTERFERON-INDUCIBLE PROTEIN-10, Leukemia & lymphoma, 29(3-4), 1998, pp. 315
Authors:
ROSKROW MA
GANSBACHER B
Citation: Ma. Roskrow et B. Gansbacher, RECENT DEVELOPMENTS IN GENE-THERAPY FOR ONCOLOGY AND HEMATOLOGY, Critical reviews in oncology/hematology, 28(3), 1998, pp. 139-151
Authors:
SCOTTTAYLOR TH
GALLARDO HF
GANSBACHER B
SADELAIN M
Citation: Th. Scotttaylor et al., ADENOVIRUS FACILITATED INFECTION OF HUMAN-CELLS WITH ECOTROPIC RETROVIRUS, Gene therapy, 5(5), 1998, pp. 621-629
Authors:
SCOTTTAYLOR T
SADELAIN M
GANSBACHER B
Citation: T. Scotttaylor et al., EFFICIENT RETROVIRAL GENE-TRANSFER IN HUMAN-CELLS BY EXPRESSION OF THE ECOTROPIC MOLONEY MURINE LEUKEMIA-VIRUS RECEPTOR BY ADENOVIRUS, Cancer gene therapy, 4(5), 1997, pp. 325-326
Authors:
SARRIS AH
DALIANI D
JACKOW C
PUGH W
GANSBACHER B
CABANILLAS F
DUVIC M
Citation: Ah. Sarris et al., INDUCTION OF INTERFERON-INDUCIBLE PROTON-10 BY TUMOR-NECROSIS-FACTOR-ALPHA INTERFERON-GAMMA, BUT NOT BY HTLV-I IS LIKELY TO EXPLAIN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA, Journal of investigative dermatology, 109(3), 1997, pp. 489-489
Authors:
ZIER KS
GANSBACHER B
Citation: Ks. Zier et B. Gansbacher, TUMOR-CELL VACCINES THAT SECRETE INTERLEUKIN-2 (IL-2) AND INTERFERON-GAMMA (IFN-GAMMA) ARE RECOGNIZED BY T-CELLS WHILE RESISTING DESTRUCTION BY NATURAL-KILLER (NK) CELLS, European journal of cancer, 32A(8), 1996, pp. 1408-1412
Authors:
ZIER KS
GANSBACHER B
Citation: Ks. Zier et B. Gansbacher, IL-2 GENE-THERAPY OF SOLID TUMORS - AN APPROACH FOR THE PREVENTION OFSIGNAL-TRANSDUCTION DEFECTS IN T-CELLS, Journal of molecular medicine, 74(3), 1996, pp. 127-134
Authors:
ZIER K
GANSBACHER B
SALVADORI S
Citation: K. Zier et al., PREVENTING ABNORMALITIES IN SIGNAL-TRANSDUCTION OF T-CELLS IN CANCER - THE PROMISE OF CYTOKINE GENE-THERAPY, Immunology today, 17(1), 1996, pp. 39-45
Authors:
WICKE I
GANSBACHER B
Citation: I. Wicke et B. Gansbacher, USE OF THE THYMIDINE KINASE GENE IN THE T REATMENT OF SOLID TUMORS, Der Internist, 37(4), 1996, pp. 369-373
Authors:
HANTZOPOULOS PA
GANSBACHER B
Citation: Pa. Hantzopoulos et B. Gansbacher, GENE-THERAPY - STATE-OF-THE-ART AND PERSP ECTIVES, Chirurg, 67(10), 1996, pp. 980-983
Authors:
GUARINI A
GANSBACHER B
CRONIN K
FIERRO MT
FOA R
Citation: A. Guarini et al., IL-2 GENE-TRANSDUCED HUMAN HLA-A2 MELANOMA-CELLS CAN GENERATE A SPECIFIC ANTITUMOR CYTOTOXIC T-LYMPHOCYTE RESPONSE, Cytokines and molecular therapy, 1(1), 1995, pp. 57-64
Authors:
ZIER KS
GANSBACHER B
Citation: Ks. Zier et B. Gansbacher, THE IMPACT OF GENE-THERAPY ON T-CELL FUNCTION IN CANCER, Human gene therapy, 6(10), 1995, pp. 1259-1264
Authors:
SALVADORI S
GANSBACHER B
WERNICK I
TIRELLI S
ZIER K
Citation: S. Salvadori et al., B7-1 AMPLIFIES THE RESPONSE TO INTERLEUKIN-2-SECRETING TUMOR VACCINESIN-VIVO, BUT FAILS TO INDUCE A RESPONSE BY NAIVE CELLS IN-VITRO, Human gene therapy, 6(10), 1995, pp. 1299-1306
Authors:
BLAESE M
BLANKENSTEIN T
BRENNER M
COHENHAGUENAUER O
GANSBACHER B
SORRENTINO B
VELU T
Citation: M. Blaese et al., EUROPEAN SCHOOL OF ONCOLOGY POSITION PAPER - GENE-THERAPY FOR THE MEDICAL ONCOLOGIST, European journal of cancer, 31A(9), 1995, pp. 1531-1537
Authors:
GANSBACHER B
Citation: B. Gansbacher, CYTOKINE GENE-TRANSFER - FIRST CLINICAL-TRIALS, European journal of cancer, 31A, 1995, pp. 30-30
Authors:
BLAESE M
BLANKENSTEIN T
BRENNER M
COHENHAGUENAUER O
GANSBACHER B
RUSSELL S
SORRENTINO B
VELU T
Citation: M. Blaese et al., VECTORS IN CANCER-THERAPY - HOW WILL THEY DELIVER, Cancer gene therapy, 2(4), 1995, pp. 291-297
Authors:
HARA I
NGUYEN H
TAKECHI Y
GANSBACHER B
CHAPMAN PB
HOUGHTON AN
Citation: I. Hara et al., REJECTION OF MOUSE MELANOMA ELICITED BY LOCAL SECRETION OF INTERLEUKIN-2 - IMPLICATING MACROPHAGES WITHOUT T-CELLS OR NATURAL-KILLER-CELLS IN TUMOR REJECTION, International journal of cancer, 61(2), 1995, pp. 253-260
Authors:
TJUVAJEV J
GANSBACHER B
DESAI R
BEATTIE B
KAPLITT M
MATEI C
KOUTCHER J
GILBOA E
BLASBERG R
Citation: J. Tjuvajev et al., RG-2 GLIOMA GROWTH ATTENUATION AND SEVERE BRAIN EDEMA CAUSED BY LOCALPRODUCTION OF INTERLEUKIN-2 AND INTERFERON-GAMMA, Cancer research, 55(9), 1995, pp. 1902-1910
Authors:
TJUVAJEV JG
STOCKHAMMER G
DESAI R
UEHARA H
WATANABE K
GANSBACHER B
BLASBERG RG
Citation: Jg. Tjuvajev et al., IMAGING THE EXPRESSION OF TRANSFECTED GENES IN-VIVO, Cancer research, 55(24), 1995, pp. 6126-6132
Authors:
CIGNETTI A
GUARINI A
CARBONE A
FORNI M
CRONIN K
FORNI G
GANSBACHER B
FOA R
Citation: A. Cignetti et al., TRANSDUCTION OF THE IL2 GENE INTO HUMAN ACUTE-LEUKEMIA CELLS - INDUCTION OF TUMOR REJECTION WITHOUT MODIFYING CELL-PROLIFERATION AND IL2 RECEPTOR EXPRESSION, Journal of the National Cancer Institute, 86(10), 1994, pp. 785-791
Authors:
ALOSCO T
GANSBACHER B
BANKERT R
TAKITA H
PETRELLI N
Citation: T. Alosco et al., HUMAN LUNG-TUMOR CELL SECRETION OF INTERLEUKIN-2 FOR PROTECTION AGAINST TUMOR ENGRAFTMENT, Annals of surgical oncology, 1(3), 1994, pp. 229-235
Authors:
FOA R
GUARINI A
CIGNETTI A
CRONIN K
ROSENTHAL F
GANSBACHER B
Citation: R. Foa et al., CYTOKINE GENE-THERAPY - A NEW STRATEGY FOR THE MANAGEMENT OF CANCER-PATIENTS, Natural immunity, 13(2-3), 1994, pp. 65-75
Authors:
GANSBACHER B
Citation: B. Gansbacher, CLINICAL-APPLICATION OF IMMUNOSTIMULATORY GENE-TRANSFER, European journal of cancer, 30A(8), 1994, pp. 1187-1190
Authors:
SALVADORI S
GANSBACHER B
ZIER K
Citation: S. Salvadori et al., FUNCTIONAL DEFECTS ARE ASSOCIATED WITH ABNORMAL SIGNAL-TRANSDUCTION IN T-CELLS OF MICE INOCULATED WITH PARENTAL BUT NOT IL-2 SECRETING TUMOR-CELLS, Cancer gene therapy, 1(3), 1994, pp. 165-170
Authors:
ZIER KS
SALVADORI S
CRONIN KC
GANSBACHER B
Citation: Ks. Zier et al., VACCINATION WITH IL-2-SECRETING TUMOR-CELLS STIMULATES THE GENERATIONOF IL-2-RESPONSIVE T-CELLS AND PREVENTS THE DEVELOPMENT OF UNRESPONSIVENESS, Cancer gene therapy, 1(1), 1994, pp. 43-50